Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Johann F Mols"'
Autor:
Nicolas Lecrenier, Pierre Beukelaers, Romulo Colindres, Desmond Curran, Carine De Kesel, Jean-Philippe De Saegher, Arnaud M Didierlaurent, Edouard Y Ledent, Johann F Mols, Tomas Mrkvan, Marie Normand-Bayle, Lidia Oostvogels, Fernanda Tavares Da Silva, Ventzislav Vassilev, Carlota Vinals, Alain Brecx
Publikováno v:
Expert Review of Vaccines, Vol 17, Iss 7, Pp 619-634 (2018)
Introduction: GSK has developed a two-dose adjuvanted recombinant zoster vaccine (Shingrix, RZV) to protect people aged ≥50 years (50+) against herpes zoster (HZ) and its complications. RZV showed >90% efficacy against HZ, sustained over 4 years of
Externí odkaz:
https://doaj.org/article/1b760f751a8344c4b6a80c0fa43d527a
Autor:
Roman Chlibek, José M Bayas, Harry Collins, Maria Luisa Rodriguez de la Pinta, Edouard Ledent, Johann F Mols, Thomas C Heineman
Publikováno v:
The Journal of infectious diseases. 223(2)
Autor:
Caroline C, Burteau, Françis R, Verhoeye, Johann F, Mols, Jean-Sébastien, Ballez, Spiros N, Agathos, Yves-Jacques, Schneider
Publikováno v:
In vitro cellulardevelopmental biology. Animal. 39(7)
A strong tendency is currently emerging to remove not only serum but also any product of animal origin from animal cell culture media during production of recombinant proteins. This should facilitate downstream processing and improve biosafety. One w